ICD-10 Coding for Staphylococcal Enterotoxin B Dermatitis(B95.61, B95.61U, L20.89)
Learn about the ICD-10 coding and documentation requirements for staphylococcal enterotoxin B dermatitis, including primary and ancillary codes.
Complete code families applicable to Staphylococcal Enterotoxin B Dermatitis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| L23.9 | Allergic contact dermatitis, unspecified cause | Use when SEB is confirmed as the direct cause of contact dermatitis. |
|
| L20.89 | Other atopic dermatitis | Use when atopic dermatitis is exacerbated by SEB. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutStaphylococcal Enterotoxin B Dermatitis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Staphylococcal Enterotoxin B Dermatitis.
Omitting B95.61 when Staphylococcus is cultured
Impact
Clinical: Incomplete clinical picture, Regulatory: Potential audit risk, Financial: Loss of reimbursement for comorbidity
Mitigation
Always check lab results for organism identification, Include B95.61 when applicable
Using L21.9 for SEB-induced dermatitis
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use L23.9 or L20.89 with B95.61 if SEB is confirmed.
Incorrect coding of SEB dermatitis
Impact
Failure to document SEB involvement can lead to incorrect coding.
Mitigation
Ensure documentation includes lab confirmation of SEB.